Horizon Pharma | HZNP - Ativos



Ativos Alterar Data
AbbVie USD 133.96B 62M 2025-12
ALKERMES USD 2.49B 157.48M 2025-12
Amgen USD 90.59B 445M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Bausch Health Companies USD 26.37B 458M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Cara Therapeutics USD 43.75M 4.8M 2025-06
Coherus Biosciences USD 258.34M 258.18M 2025-12
Eli Lilly USD 112.48B 2.46B 2025-12
Merck USD 129.55B 12.02B 2025-09
Novartis USD 107.29B 2.89B 2025-09
Pacira USD 1.26B 32.66M 2025-12
Perrigo USD 8.54B 1.55B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Prestige Brands USD 3.49B 52.46M 2025-12
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Takeda JPY 15.41T 938.47B 2025-12
Xeris Pharmaceuticals USD 370.19M 35.5M 2025-09
Zoetis USD 15.47B 308M 2025-12